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Keratinocytes produce many cytochemokines that are involved in the pathogenesis of skin disorders. In particular,
the CC chemokines thymus and activation-regulated chemokine (TARC)/macrophage-derived chemokine (MDC)
play an important role in the inﬁltration of Th2 cells. This study was undertaken to examine the regulatory effects of
interleukin (IL)-4, IL-13, and interferon (IFN)-c on TARC/MDC production in the human keratinocyte cell line HaCaT.
HaCaT cells spontaneously secrete TARC and MDC. The production of TARC/MDC was downregulated by IL-4/IL-
13, whereas it was upregulated by IFN-c. To explore these regulatory mechanisms, we investigated the capacity of
cytokines to regulate expression of several adhesion molecules that may affect TARC/MDC production. Of the
adhesion molecules examined, the constitutive surface expression of E-cadherin was downregulated by IL-4/IL-13,
but was upregulated by IFN-c. Moreover, disruption of the homophilic adherence of E-cadherin by anti-E-cadherin
antibody or calcium chelation abolished the production of TARC/MDC. We further examined the distribution of the
adherens junction complex composed of E-cadherin, a-catenin, b-catenin, and c-catenin. IL-4/IL-13 decreased the
levels of membrane staining for adherens junction proteins, whereas IFN-c increased membrane staining. Taken
together, these results suggest that IL-4/IL-13 and IFN-c induce alternations in the distribution of adherens
junctions in a different fashion and thereby contribute to the reciprocal regulation of TARC/MDC production.
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Keratinocytes produce a vast repertoire of cytokines,
including interleukins, growth factors, colony-stimulating
factors, and chemokines. The pattern of cytochemokines
secreted locally plays a critical role in modulating the nature
of tissue inflammation (Uchi et al, 2000). Thymus and
activation-regulated chemokine (TARC/CCL17) and macro-
phage-derived chemokine (MDC/CCL22) are ligands for the
CC chemokine receptor 4 (CCR4), which is expressed
selectively on Th2 cells. Ligation of TARC/MDC and CCR4
plays an important role in the migration of Th2 cells into
inflamed tissues (Imai et al, 1999; Yoshie et al, 2001). Very
recently, serum levels of TARC and MDC were shown to
correlate well with disease severity in Th2-prone skin
disorders, such as atopic dermatitis and mycosis fungoides
(Kakinuma et al, 2001, 2002, 2003). Both chemokines are
produced from various cell types, such as dendritic cells,
T cells, fibroblasts, and epithelial cells (Alferink et al, 2003;
Vulcano et al, 2001; Hirata et al, 2003; Fukuda et al, 2003;
Albanesi et al, 2001).
Immunohistologic staining has revealed that keratino-
cytes express TARC and MDC in the lesional, but not in the
nonlesional, skin of atopic dermatitis in vivo (Vestergaard
et al, 2000; Kakinuma et al, 2001; Horikawa et al, 2002). In
addition, the expression of TARC was demonstrated in the
lesional skin of atopic model mice NC/Nga (Vestergaard
et al, 1999). Moreover, the expression of TARC was
detected in the lesional skin of mycosis fungoides (Kakinu-
ma et al, 2003). In sharp contrast to these in vivo reports,
cultured normal human keratinocytes were reported to be
capable of secreting only MDC, but not TARC, whereas they
expressed mRNA for both cytokines (Albanesi et al, 2001;
Horikawa et al, 2002; Tsuda et al, 2003). On the other hand,
a spontaneously immortalized, nontumorigenic human
HaCaT keratinocyte cell line has been described to
synthesize and secrete TARC upon stimulation with inter-
feron (IFN)-g and tumor necrosis factor (TNF)-a (Vestergaard
et al, 2000; Tsuda et al, 2003). The production of TARC by
keratinocytes was also confirmed by culturing a murine
keratinocyte cell line (PAM212) in the presence of IFN-g,
Abbreviations: BSA, bovine serum albumin; FITC, fluores-
cein isothiocyanate; IFN, interferon; IL, interleukin; MDC,
macrophage-derived chemokine; p-, phospho-; PBS, phos-
phate-buffered saline; TARC, thymus and activation-regu-
lated chemokine; TNF, tumor necrosis factor.
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TNF-a, or interleukin (IL)-1b (Vestergaard et al, 1999).
Although the results, thus far, remain controversial, HaCaT
keratinocytes may mimic the lesional keratinocytes of
atopic dermatitis and mycosis fungoides.
To understand the regulatory mechanisms for TARC and
MDC production in keratinocytes, we investigated the
effects of IL-4, IL-13, and IFN-g on TARC and MDC
production by HaCaT keratinocytes. We found that IL-4/
IL-13 and IFN-g induce different alternations in the distribu-
tion of adherens junctions and, thereby, contribute to the
reciprocal regulation of TARC and MDC production.
Results
HaCaT cells, but not normal human keratinocytes,
secreted TARC and MDC spontaneously We examined
the production of TARC and MDC from normal human
keratinocytes and HaCaT keratinocytes. As previously
documented (Albanesi et al, 2001; Horikawa et al, 2002;
Tsuda et al, 2003), both normal human keratinocytes and
HaCaT keratinocytes expressed mRNA for TARC and MDC
(Fig 1A). We examined whether normal keratinocytes and
HaCaT keratinocytes express the IL-4/IL-13 and IFN-g
receptor components. As shown in Fig 1A, mRNA for IL-
4Ra, IL-13Ra1, and IL-13Ra2 was expressed, whereas
mRNA for IL-2Rg was undetectable. For IFN-gR1 expres-
sion, we examined using flow cytometric analysis. As
shown in Fig 1B, IFN-gR1 was expressed on the surface
of both normal keratinocytes and HaCaT keratinocytes.
Only HaCaT keratinocytes produced substantial amounts of
TARC and MDC (Fig 1C). Because the spontaneous
secretion of TARC and MDC by HaCaT keratinocytes
achieved a plateau after 48 h of incubation, the following
experiments were designed with 48 h of incubation.
The spontaneous production of TARC/MDC mRNA and
protein was suppressed by IL-4/IL-13, but enhanced by
IFN-c We addressed the effects of IL-4/IL-13 or IFN-g on
TARC/MDC production. HaCaT cells were cultured with or
without 0.1 to 10 ng per ml each of IL-4, IL-13, or IFN-g for
48 h. As shown in Fig 2, both IL-4 and IL-13 downregulated
the spontaneous production of TARC/MDC in a concentra-
tion-dependent manner. In contrast, IFN-g augmented the
spontaneous production of TARC/MDC. We evaluated
whether the regulation of TARC/MDC production by IL-4/
IL-13 or IFN-g accompanied the regulation of TARC/MDC
mRNA expression using RT-PCR. As shown in Fig 3A, in
HaCaT keratinocytes, TARC and MDC mRNA expression
was suppressed as early as 1 h after the addition of either
IL-4 or IL-13 and gradually decreased thereafter. In
contrast, TARC and MDC mRNA expression was enhanced
significantly for 24 h by IFN-g. Like HaCaT cells, TARC/MDC
mRNA expression was suppressed by IL-4 and IL-13, but
enhanced by IFN-g for 24 h of incubation in normal human
keratinocytes (Fig 3B).
E-cadherin expression was downregulated by IL-4 or
IL-13, but was upregulated by IFN-c To explore
the regulatory mechanisms involved, we investigated the
capacity of IL-4/IL-13 or IFN-g to induce or regulate the
expression of several adhesion molecules that may affect
TARC and MDC production. After 48 h of incubation with the
medium alone or with 10 ng per mL IL-4, IL-13, or IFN-g, the
expression of adhesion molecules was determined by flow
cytometry. As indicated in Fig 4, of the adhesion molecules
examined, the constitutive expression of E-cadherin and
CD54 was downregulated by IL-4, whereas this expression
was upregulated by IFN-g in HaCaT keratinocytes. IL-13
presented similar results as that observed for IL-4 (data not
shown). Nevertheless, neither CD11b nor CD18, which are
ligands for CD54, was induced, even after cytokine
stimulation. In normal human keratinocytes, IFN-g also
upregulated the E-cadherin expression and IL-4/IL-13
downregulated its expression (Table II).
Disruption of homophilic adhesion of E-cadherins
abolished the spontaneous production of TARC and
MDC To determine whether the homophilic interaction
between E-cadherins might be involved in the regulation
of TARC/MDC production, the production of TARC and
MDC was assessed after using an anti-E-cadherin antibody
that blocks binding activity. The anti-E-cadherin antibody
(1–30 mg/ml) dramatically reduced TARC/MDC production in
a concentration-dependent manner (Fig 5). To confirm the
participation of E-cadherin in TARC/MDC production, we
examined the effect of Ca2þ depletion on TARC/MDC
production. As indicated in the top part of Fig 6, the
constitutive expression of E-cadherin was suppressed by
Ca2þ -free medium treatment and was more potently
suppressed by EGTA plus Ca2þ -free medium treatment.
In accordance with the levels of E-cadherin expression,
TARC/MDC production was inhibited (bottom part of Fig 6).
These data suggest that the levels of E-cadherin expression
may contribute to the regulation of TARC/MDC production
by HaCaT cells. Thus, we focused our experiments on the
adherens junction complex composed of E-cadherin, a-
catenin, b-catenin, and g-catenin.
IL-4/IL-13 and IFN-c induced alternations in the distribu-
tion of adherens junction proteins We examined whether
IL-4/IL-13 or IFN-g induced any change on the amount of
the each adherens junction protein. As shown in Fig 7, no
significant changes in the amount of each adherens junction
protein were detected in IL-4/IL-13- or IFN-g-treated cells.
These data indicate that the level of E-cadherin expression
by IL-4/IL-13 or IFN-g is not regulated by changes in the
amount of adherens junction proteins. We then examined
the distribution of the adherens junction complex by
confocal immunofluorescent microscopy. As shown in Fig
8, in nontreated cells, staining for E-cadherin, a-catenin, b-
catenin, and g-catenin was localized to the cell membrane.
Nevertheless, membrane staining for E-cadherin and
catenins was reduced after IL-4/IL-13 stimulation, whereas
the immunoreactivity for surface E-cadherin was increased
after IFN-g stimulation (Fig 9). Taken together, these results
may indicate that IL-4 and IL-13 promote the internalization
of adherens junction complex, leading to a downregulation
of TARC/MDC production. In contrast, IFN-g inhibits the
internalization of adherens junction complex, thus upregu-
lating TARC and MDC production.
We also investigated whether the activation of ERK1/2,
p38 MAPK, and JNK was triggered by IL-4, IL-13, and
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IFN-g. The activation of p38 MAPK or JNK by any cytokine
was not detected (data not shown). In contrast, ERK1/2 was
spontaneously activated, but was not regulated by cyto-
kines (Fig 10).
Discussion
TARC and MDC are very potent chemokines for CCR4þ
Th2 cells (Kawasaki et al, 2001; Yoshie et al, 2001). These
chemokines are produced from various cell types such as
immunocompetent dendritic cells, T cells, and endothelial
cells (Alferink et al, 2003; Vulcano et al, 2001; Hirata et al,
2003; Fukuda et al, 2003; Albanesi et al, 2001). Because
keratinocytes are one of the candidates capable of
producing TARC and MDC, the regulatory mechanisms
involved in their secretion are of interest. In this study, we
compared TARC and MDC secretion from normal human
keratinocytes and HaCaT keratinocytes. Consistent with
previous findings, HaCaT keratinocytes, but not normal
human keratinocytes, secreted TARC and MDC sponta-
neously. The upregulation of the ERK1/2 signaling pathway
in the HaCaT cells may explain this difference. This
hypothesis is supported by the fact that an ERK1/2 inhibitor
inhibited TARC production by HaCaT keratinocytes (our
unpublished data). Further study is necessary to elucidate
this point.
HaCaT keratinocytes constitutively express IL-4Ra, IL-
13Ra1, and IFN-gR1 on their surface, similar to normal
human keratinocytes (David et al, 2001; Nickoloff et al,
1987; Akaiwa et al, 2001). Therefore, we investigated the
effect of IFN-g (Th1 cytokine) and IL-4/IL-13 (Th2 cytokine)
on TARC and MDC production. Interestingly, IFN-g sig-
nificantly augmented and IL-4/IL-13 inhibited TARC and
MDC production in a concentration-dependent manner.
Many investigators have reported the regulatory effects of
cytokines on TARC/MDC production. PAM 212 cells, a
murine keratinocyte cell line, produced TARC after stimula-
tion with either TNF-a or IFN-g (Vestergaard et al, 1999). IL-
10 greatly augmented the TNF-aþ IFN-g-induced TARC
production by HaCaT cells (Vestergaard et al, 2001). In
bronchial epithelial cells, Sekiya et al (2000) reported that
A549 and BEAS-2B cells produce TARC protein after dual
stimulation with TNF-aþ IL-4. Moreover, IFN-g synergisti-
cally upregulated the TNF-aþ IL-4-induced TARC produc-
tion. Terada et al (2001) reported that combined stimulation
with IL-4/IL-13 and TNF-a induced TARC expression in
nasal epithelial cells. Similarly, human corneal fibroblasts
have been shown to produce TARC only in the presence of
both IL-4 and TNF-a (Kumagai et al, 2000). In monocytes,
IL-4/IL-13 induces MDC production, whereas IFN-g inhibits
it (Andrew et al, 1998; Bonecchi et al, 1998). In HaCaT
keratinocytes, the production of TARC and MDC are
reciprocally regulated by Th1 and Th2 cytokines.
E-cadherin is a potent cell adhesion molecule and is
indispensable in the maintenance of the structural and
functional rigidity of the epithelium. The blockage of
cadherins by antibodies induced tissue destruction and
the dissociation of the cultured tissue (Vestweber and
Kelmer, 1985). Also, misregulated E-cadherin expression or
Figure 1
Phenotypic and functional profiles. (A) The expression of mRNA for IL-
4/IL-13 receptor components and TARC/MDC was analyzed by RT-
PCR. (B) The surface expression of IFN-gR1 was analyzed by flow
cytometry. (C) A time-course study of spontaneous TARC/MDC
production in HaCaT cells. All values are the mean  SEM of triplicate
experiments. po0.05; po0.005.
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function can alter the pattern of epithelial cell growth, and
differentiation (Gumbiner, 1996).
Several investigators have reported the regulation of E-
cadherin expression by IL-4, IL-13, and IFN-g (Fenyves et al,
1993; Kanai et al, 2000). In bovine microvascular endothelial
cells, IFN-g upregulated E-cadherin expression (Fenyves
et al, 1993). In a human colon cancer cell line (colo205), IL-4
and IL-13 inhibit cell–cell adhesion by downregulating E-
cadherin (Kanai et al, 2000). In this study, we demonstrated
that the surface expression of E-cadherin in keratinocytes is
suppressed by IL-4/IL-13, but is enhanced by IFN-g.
E-cadherin-mediated cell–cell adhesion is disrupted by
Th2 cytokines, but enhanced by the Th1 cytokine. We
demonstrated that the integrity of surface E-cadherin was
closely linked to the production of TARC and MDC.
Disruption of the homophilic adhesion of E-cadherins by
anti-E-cadherin antibody blockade or by extracellular
calcium chelating abolished the spontaneous production
of TARC and MDC. This strongly suggests that E-cadherin is
involved in the regulation of TARC/MDC production. In
keratinocytes, E-cadherin forms an adherens junction
complex with b-catenin or g-catenin and a-catenin. b-
Catenin or g-catenin binds to the cytoplasmic tail of E-
cadherin and to a-catenin. a-Catenin in turn binds to the
actin cytoskeleton. This assembly is important for cell–cell
adhesion (Kondo et al, 1998; Kobayashi et al, 2000; Pece
and Gutkind, 2000; Hu et al, 2001). Interestingly, IL-4/IL-13
enhanced the internalization of E-cadherin/catenins com-
plex into the cytoplasm and disrupted surface E-cadherin
expression, resulting in the downregulation of TARC/MDC
production. Conversely, IFN-g augmented the surface
membrane distribution of E-cadherin/catenins, resulting in
the upregulation of TARC/MDC production.
Hu et al (2001) reported that in peroxovanadate-treated
human keratinocytes, the distribution of adherens junction
proteins is altered with the tyrosine phosphorylation of
Figure 2
Effects of IL-4/IL-13 and IFN-g on TARC/MDC
production. Cells were incubated with medium
alone or with IL-4, IL-13, or IFN-g for 48 h. After
incubation, the concentrations of TARC/MDC in
the supernatants were quantified by ELISA
procedures. Results represent the mean 
SEM of triplicate experiments. po0.05 and
po0.005 indicate a statistically significant
difference versus unstimulated control cells.
Figure 3
Effects of IL-4/IL-13 and IFN-g on TARC/MDC mRNA expression. (A) HaCaT cells were incubated with medium alone or with 10 ng per mL each of
IL-4, IL-13, or IFN-g for the indicated times. The ratio of TARC/MDC mRNA to b-actin mRNA was determined by quanti-tative real-time RT-PCR.
Results represent the mean  SEM of triplicate experiments. po0.05; po0.005. (B) Normal human keratinocytes were incubated with medium
alone or with 10 ng per mL each of IL-4 or IFN-g for 24 h. mRNA for TARC/MDC was analyzed by RT-PCR. Like IL-4, IL-13 gave similar results (data
not shown).
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b-catenin and g-catenin. Thus, we examined the tyrosine
phosphorylation of adherens junction proteins in the
presence of cytokines. No tyrosine phosphorylation was
induced by any cytokine stimulation (data not shown).
Nelms et al (1999) described that in the A431 keratinocyte
cell line, IL-4 not only activated the JAK/STAT pathway, but
also regulated the activity of various members of the MAPK
family, which is in contrast to what has been described in
most hematopoietic cells. Therefore, we investigated
whether the activation of ERK1/2, p38 MAPK, and JNK
were modulated by IL-4, IL-13, and IFN-g. Our results show
that the activation of p38 MAPK, JNK, or ERK1/2 was not
modified by any cytokine.
The function of the keratinocyte is known to be regulated
via intracellular signaling pathways triggered by growth
factors (Hashimoto, 2000). We explored the role of some
growth factors in the reciprocal regulation of TARC/MDC
production by IL-4/IL-13 and IFN-g. The growth factors
examined, PDGF-AB, IL-6, amphiregulin, EGF, basic FGF,
and PDGF-BB, had no effect on the regulation of TARC/
MDC production by HaCaT cells (data not shown).
In conclusion, our results suggest that in HaCaT
keratinocytes, IL-4/IL-13 and IFN-g induce differing altera-
tions in the distribution of adherens junctions and, thereby,
contribute to the reciprocal regulation of TARC and MDC
production. Although the molecular mechanisms triggered
by these cytokines remain unclear, our findings that TARC
and MDC production are regulated in parallel with E-
cadherin expression in keratinocytes may provide a new
clue for understanding the orchestrated regulation of TARC/
MDC production.
Figure 4
Effects of IL-4 and IFN-g on CD11b, CD18,
CD54, and E-cadherin expression. Cells were
cultured with medium alone or with 10 ng per
mL each of IL-4 or IFN-g for 48 h. Expression of
these adhesion molecules was analyzed by flow
cytometry. Representative data are shown
(n¼3). Like IL-4, IL-13 gave similar results (data
not shown).
Table II. Effects of IL-4, IL-13, and IFN-g on E-cadherin
expression in normal human keratinocytesa
Mean
ﬂuorescence
intensity
Signiﬁcance
versus
medium
Medium 7.01  0.63
IL-4 5.69  0.61 po0.2
IL-13 5.34  0.83 po0.2
IFN-g 8.90  0.87 po0.2
aCells were cultured with medium alone or with 10 ng per mL each of
IL-4, IL-13, or IFN-g for 48 h. Expression of E-cadherin was analyzed by
flow cytometry. Results represent the mean fluorescence intensi-
ty  SEM of triplicate experiments.
Table I. Sequences of primers used for PCR
Ampliﬁed
RNA
Primer sequence Size of
ampliﬁed
product
(bp)
IL-4Ra 50-GCTATGTCAGCATCACCAAGA-30 830
50-TTCTACTTCCTCCAGGTGTCT-30
IL-2Rg 50-TTTCTTCCTGACCACTATGCC-30 479
50-CAGTCCAGCTGTGGTCCCAG-30
IL-13Ra1 50-GGAGCCAGCTCAATTTGTAG-30 510
50-CACACGGGAAGTTAAAGGCA-30
IL-13Ra2 50-ATGGCTTTCGTTTGCTTGGCTA-30 620
50-TAGTCTGATGCCTCCAAATAGG-30
TARC 50-ATGGCCCCACTGAAGATGCT-30 351
50-TGAACACCAACGGTGGAGGT-30
MDC 50-GCTCGCCTACAGACTGCACTC-
CTG-30
268
50-GCTTATTGAGAATCATCTTCACC-
CAGG-30
G3PDH 50-TGAAGGTCGGAGTCAACGGATTT-
GGT-30
983
5’-CATCTGGGCCATGAGGTCCACC-
AC-30
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Materials and Methods
Reagents Recombinant human IL-4, IL-13, and IFN-g were
purchased from Genzyme (Cambridge, MA). ELISA kits for TARC
and MDC were obtained from R&D Systems (Minneapolis, MN). All
reagents for quantitative real-time PCR were from Roche Molecular
Biochemicals (Germany). For flow cytometry staining, polyclonal
anti-IFN-gR1 antibody was obtained from R&D systems (Minnea-
polis, MN). Fluorescein isothiocyanate (FITC)-conjugated mono-
clonal anti-CD11b antibody was purchased from Beckman Coulter
(Fullerton, CA). FITC-conjugated monoclonal anti-CD18 antibody
was purchased from Dako (Denmark). FITC-conjugated mono-
clonal anti-CD54 antibody was purchased from Serotec (UK).
Monoclonal anti-E-cadherin antibody (Immunotech, France) was
used for flow cytometry as well as for blocking experiments.
Phycoerythrin-conjugated F(ab’)2 fragments of goat anti-mouse
immunoglobulin antibody was from Biosource (Camarillo, CA).
Streptavidin-phycoerythrin was purchased from Becton Dickinson
(San Jose, CA). For immunoblotting and immunofluorescent
staining, monoclonal anti-a-catenin, monoclonal anti-b-catenin,
horseradish peroxidase-conjugated goat anti-mouse IgG and
horseradish peroxidase-conjugated goat anti-rabbit IgG were from
Zymed (South San Francisco, CA). Monoclonal anti-E-cadherin
and anti-g-catenin antibodies were from Transduction Laboratories
(Lexington, KY). Polyclonal anti-phospho (p)-ERK1/2 (Thr202,
Tyr204), anti-p-p38 MAPK (Thr180, Tyr182), anti-p-JNK (Thr183,
Tyr185), anti-ERK1/2, anti-p38 MAPK, and anti-JNK antibodies
were obtained from Cell Signaling Technology (Beverly, MA). FITC-
conjugated F(ab’)2 fragments of goat anti-mouse immunoglobulin
antibody was from Biosource (Camarillo, CA).
Cell culture The HaCaT keratinocyte cell line was provided by
N. E. Fusenig, DKFZ Heidelberg (Boukamp et al, 1988). HaCaT
cells were maintained in Dulbecco’s modified Eagle’s medium
(Gibco-BRL, Grand Island, NY) with 10% heat-inactivated fetal
bovine serum (Gibco-BRL), 100 U per mL penicillin, 100 mg per mL
streptomycin (Gibco-BRL) at 371C. In specific experiments
described below, cells were serum-starved for 24 h before
Figure 5
Inhibitory effect of anti-E-cadherin antibody on
the spontaneous production of TARC/MDC.
Cells were incubated with or without the anti-
E-cadherin antibody or control antibody for 48
h. Levels of TARC/MDC in the supernatants
were quantified by ELISAs. Results represent
the mean  SEM of triplicate experiments.
po0.05; po0.005.
Figure 6
Effects of Ca2þ depletion on E-cadherin
expression and TARC/MDC production. Cells
were cultured with ordinary Ca2þ -containing
medium for 48 h, with Ca2þ -free medium for 48
h, or with Ca2þ -free medium for 47 h followed
by EGTA (4 mM) treatment for 1 h. After
incubation, E-cadherin expression and TARC/
MDC production were determined using flow
cytometry and ELISA procedures, respectively.
Representative data (in top panels) and mean-
 SEM (in bottom panels) are shown (n¼3).
po0.05; po0.005.
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treatment with or without IL-4, IL-13, or IFN-g. Normal human
keratinocytes from neonatal foreskin (Kurabou, Osaka, Japan)
were grown initially in keratinocyte basal medium (HuMedia-KB2,
Kurabou) containing 0.15 mM calcium supplemented with 0.1 ng
per mL epidermal growth factor, 0.4% bovine pituitary extract,
50 mg per mL gentamycin, and 50 ng per mL amphotericin B.
ELISA Concentrations of TARC and MDC in culture supernatants
were measured by commercially available ELISA kits according to
the manufacturer’s instructions. These ELISA procedures enabled
detection of TARC concentrations of greater than 15.6 pg per mL
and MDC concentrations of greater than 62.5 pg per mL.
RT-PCR Total RNA was extracted using an RNeasy Mini kit
(Qiagen, Hilden Germany). RT was performed using oligo(dT)12-18
primer (Invitrogen Corp., Carlsbad, CA) and a Superscript II RNase
reverse transcriptase kit (Invitrogen Corp.) according to the
manufacturer’s protocol. To analyze the expression of IL-4/IL-13
receptor components and TARC/MDC in unstimulated HaCaT
cells, semiquantitative PCR was performed on a thermal cycler
(TaKaRa, Tokyo, Japan) using a Pyrobest DNA polymerase kit
(TaKaRa, Tokyo, Japan). The sequences of the PCR primers are
shown in Table I. G3PDH was used as a reference gene. The
thermal cycling conditions were set to 981C for 5 min, followed by
28 cycles of 981C for 10 s, 621C for 30 s, 721C for 1 min, and 721C
for 4 min. The amplified products were subjected to electrophor-
esis on 2% agarose gels and visualized by staining with ethidium
bromide. We investigated whether 10 ng per mL each of IL-4, IL-
13, or IFN-g had any effect on the expression of TARC/MDC
mRNA. Quantitative real-time PCR was performed on a LightCycler
(Roche Molecular Biochemicals, Germany) in LightCycler capil-
laries using the LightCycler FastStart DNA master SYBR green I kit
(Roche Molecular Biochemicals) and LightCycler primer sets for
TARC (CCL17), MDC (CCL22), and b-actin (Roche Molecular
Biochemicals) were used. Thermal cycler conditions were set to
951C for 10 min, followed by 35 cycles of 951C for 10 s, 681C for
10 s, and 721C for 16 s. To control for the specificity of the
amplification products, a melting curve analysis was performed.
No amplification of unspecific products was observed. The copy
number was calculated from a standard curve.
Flow cytometry The surface expression of IFN-gR1 or adhesion
molecules was determined by flow cytometry after 0 or 48 h of
incubation with or without 10 ng per mL each of IL-4, IL-13, or IFN-
g. A total of 5  105 cells were suspended in 50 mL of phosphate-
buffered saline (PBS) with 1% bovine serum albumin (BSA) and
0.05% NaN3 (FACS buffer). To analyze IFN-gR1 expression, the
cells were sequentially incubated with biotinylated anti-IFN-gR1
antibody for 30 min at 41C and streptavidin-phycoerythrin for 30
min at 41C. Expression of CD11b, CD18, and CD54 was assessed
by staining with the appropriate antibodies labeled with FITC for
30 min at 41C. To analyze E-cadherin expression, the cells were
first incubated with monoclonal anti-E-cadherin antibody for
30 min at 41C and detected with phycoerythrin-conjugated goat
anti-mouse immunoglobulins. In control samples, staining was
performed with isotype-matched control antibodies. After being
washed and fixed with 0.5% paraformaldehyde, the cells were
Figure 7
Analysis of adherens junction complexes composed of E-cadherin,
a-catenin, b-catenin, and g-catenin. Cells were stimulated with or
without 10 ng per mL each of IL-4, IL-13, or IFN-g for 48 h. The lysates
were immunoprecipitated with anti-E-cadherin antibody and blotted
with monoclonal antibodies to E-cadherin, a-catenin, b-catenin, or g-
catenin.
Figure 8
Distribution of adherens junction proteins. After fixation and permea-
bilization, cells were stained with monoclonal antibodies to E-cadherin,
a-catenin, b-catenin, or g-catenin and detected with FITC-conjugated
anti-mouse IgG. Stained cells were analyzed by confocal laser
microscopy. Bar, 10 mm.
Figure9
Effects of IL-4/IL-13 and IFN-g on the distribu-
tion of E-cadherin and b-catenin. Cells were
treated with medium alone or with 10 ng per mL
each of IL-4, IL-13, or IFN-g for 48 h. After
fixation and permeabilization, immunostaining,
and microscopic analyses were performed.
Similar results were obtained for a-catenin
and g-catenin (data not shown). Bar, 10 mm.
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analyzed by FACSCalibur using CELLQUEST software (Becton
Dickinson). Forward- and side-scatter gates were set to identify
living cells and 10,000 events were acquired.
Effect of anti-E-cadherin antibody on the spontaneous produc-
tion of TARC/MDC To assess the involvement of E-cadherin in
the regulation of TARC/MDC production, an anti-E-cadherin
antibody (1, 10, and 30 mg/ml) and isotype-matched control
antibody were added to the cultures for 48 h. After incubation,
the supernatant was collected for ELISA procedures for TARC/
MDC. In addition, because E-cadherin is a calcium-dependent
adhesion molecule, we examined the effect of Ca2þ depletion on
TARC/MDC production. Cells were cultured with ordinary Ca2þ -
containing medium (1.8 mM) for 48 h, with Ca2þ -free medium for
48 h, or with Ca2þ -free medium for 47 h followed by EGTA (4 mM)
treatment for 1 h. After incubation, E-cadherin expression and
TARC/MDC production were determined using flow cytometry and
ELISAs, respectively.
Immunoprecipitation and western blotting The effect of cyto-
kines on the amount of adherens junction complex composed of E-
cadherin, a-catenin, b-catenin, and g-catenin was analyzed by
western blotting. After stimulation with or without 10 ng per mL
each of IL-4, IL-13, or IFN-g for 48 h, the cells were lysed on ice
with lysis buffer containing 1% Nonidet P-40, 20 mM Tris-HCl (pH
7.4), 150 mM NaCl, 1 mM EDTA, 1 mM sodium orthovanadate,
10 mM b-glycerol phosphate, 1 mM phenylmethylsufonyl fluoride,
10 mg per mL aprotinin, and 10 mg per mL leupeptin. Protein
concentration in extracts was determined by the Bradford assay
(Bio-Rad, Hercules, CA). The lysates were precleared with protein
A-Sepharose beads (Pharmacia, Sweden) for 1 h and incubated
with anti-E-cadherin antibody (3 mg/ml) for 1 h at 41C. Immuno-
complexes were precipitated overnight with protein A-Sepharose
beads at 41C, washed with lysis buffer, eluted by boiling in SDS-
PAGE sample buffer containing 2-mercaptoethanol (Wako, Japan),
resolved on SDS-PAGE, and transferred to polyvinylidene difluor-
ide membranes (Bio-Rad). The membranes were then blocked with
2% BSA in PBS for 1 h and analyzed by western blotting with
sequential probing of the same membrane using monoclonal
antibodies to E-cadherin, a-catenin, b-catenin, and g-catenin
diluted to the manufacturer’s recommendation in antibody dilution
buffer (2% BSA, 0.1% Tween 20 in PBS) (1:250 E-cadherin, 1:1000
a-catenin, 1:1000 b-catenin, 1:2000 g-catenin) for 1 h at room
temperature. Blots were then washed in PBS with 0.1% Tween 20
and incubated for 1 h with horseradish peroxidase-conjugated
goat anti-mouse IgG diluted 1:5000 in antibody dilution buffer. After
being washed in PBS with 0.1% Tween 20, the blots were
visualized by SuperSignal West pico chemiluminescent substrate
(Pierce, Rockford, IL). When necessary, blots were stripped with
Restore western blot stripping buffer (Pierce) for 15 min at 501C,
washed in PBS with 0.1% Tween 20, and sequentially reprobed
with the appropriate antibodies.
The effects of cytokines on ERK1/2, p38 MAPK, and JNK
activation were also examined. Cells were treated with or without
10 ng per mL each of IL-4, IL-13, or IFN-g for 0 to 10 min. The
lysates were blotted with polyclonal antibodies to p-ERK1/2, p-p38
MAPK, or p-JNK. To evaluate the total amount of ERK1/2, p38
MAPK, or JNK present on the blot, the same blot was stripped and
reprobed with appropriate antibodies, respectively.
Confocal immunoﬂuorescent microscopy For immunofluores-
cent staining, HaCaT cells were grown on ethanol-sterilized glass
coverslips. Cells were incubated with or without 10 ng per mL
each of IL-4, IL-13, or IFN-g for 48 h before fixation in 3.7%
paraformaldehyde in PBS for 5 min at room temperature,
permeabilized with 0.25% Triton X-100 in PBS for 10 min at room
temperature, and blocked with 2% BSA in PBS for 15 min at room
temperature. Fixed cells were incubated overnight at 41C in a
humidity chamber with each primary antibody (E-cadherin,
a-catenin, b-catenin, and g-catenin) diluted 1:100 in antibody
dilution buffer (2% BSA, 0.1% Tween 20 in PBS). After incubation,
the coverslips of fixed cells were washed in PBS at 41C, blocked
with 2% BSA in PBS at 41C for 20 min, incubated for 60 min at 41C
in the dark with FITC-conjugated anti-mouse immunoglobulins
diluted 1:100 in antibody dilution buffer, washed in PBS at 41C, and
then mounted with FluoroGuard antifade reagent (Bio-Rad).
Stained cells were analyzed by confocal laser microscopy at
600 magnification (Bio-Rad).
Statistical analysis Statistical analyses were performed using an
unpaired Student’s t test.
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